Podcast Summary: CNBC's "Fast Money" – A Jam-Packed Week Of Earnings… And The Latest on US-China Trade (Released July 28, 2025)

Hosted by: Melissa Lee
Featuring: Tim Seymour, Karen Feiderman, Dan Nathan, Guy Adami, Stuart Kaiser, Mike Khouw, Carter Braxton Worth, Angelica Peebles
Location: NASDAQ Markets, Times Square, New York City
Air Time: Weeknights at 5 PM ET on CNBC

1. Introduction and Week Overview (00:00 - 02:43)

Melissa Lee opens the episode by outlining a highly eventful week ahead for investors. She highlights a slew of mega-cap earnings reports from giants like Microsoft, Amazon, and Apple, alongside significant economic data releases, including a pivotal Federal Reserve decision on Wednesday, PCE figures on Thursday, and the jobs report on Friday.

Key Points:

• Market Context: Both the S&P 500 and Nasdaq are trading near record highs.
• Earnings Season: Nearly a third of the S&P 500 and nine Dow components are set to report earnings.
• Economic Indicators: Fed decision, PCE, and jobs report could significantly influence market movements.

Notable Quote:

Melissa Lee (01:03): "Can the data support another move higher? The US and China wrapping up day one of their latest trade talks as the August deadline looms over the markets."

2. Market Dynamics and Trade Concerns (02:43 - 12:23)

The discussion shifts to the complexities of the current market environment, emphasizing the impact of elevated tariffs and ongoing US-China trade negotiations.

Key Points:

• Tariff Impact: Tariffs have surged to six times their levels during the Trump administration, reaching the highest in post-World War II history.
• Fed's Stance: The jobs report is crucial for the Fed’s policy decisions. A strong labor market could lead to a more hawkish Fed stance, potentially challenging the current market highs.
• Trade Negotiations: Day one of US-China trade talks in Stockholm is under scrutiny, with both sides seeking a deal before the August deadline.

Notable Quotes:

Dan Nathan (02:52): "With tariffs now being six times what they were when Trump took office... that's going to be an issue."

Stuart Kaiser (04:04): "The bond market is really stubborn here... yields are starting to tick up, which might indicate a shift in market sentiment."

3. US-China Trade Talks and Their Implications (10:47 - 37:49)

A significant portion of the episode delves into the ongoing US-China trade negotiations, their potential outcomes, and the broader implications for global markets.

Key Points:

• Negotiation Stance: Beijing is reportedly hardening its position, unwilling to let Xi Jinping "lose face" in future dealings, which may lead to stricter framework deals.
• Tariff Extensions: Discussions around extending tariff deadlines without significant concessions could lead to increased costs for consumers and sustained economic pressure.
• Market Reactions: Potential outcomes of the talks are mixed, with some analysts optimistic about Chinese tech stocks if a deal materializes, while others warn of prolonged uncertainty affecting global growth.

Notable Quotes:

Dan Nathan (11:09): "Both sides have a lot to gain by saying there's a trade deal. They’ve already kind of told us there's a trade deal."

David Riedel (33:03): "Once you have a period of time with 55% tariffs on US imports from China, that's going to start showing up on shelves pretty dramatically."

Carter Braxton Worth (37:49): "Any deal would be a very good one for all of these equities. Just the uncertainty going away plus the valuation is incredibly cheap."

4. Stock Highlights: Nike, AMD, UnitedHealth (24:08 - 30:11)

The panel discusses specific stocks that are either performing well or facing challenges amid the current market conditions.

Nike (24:08 - 26:02):

• Performance: Nike shares surged nearly 5% following upgrades from JP Morgan, driven by improved inventory management, better operating margins, and rising EPS estimates.
• Analyst Insight:

  Dan Nathan (24:08): "The valuation, at least on a sales perspective, is compelling. If you don't think that there's a major cyclical event or headwind for athleisure, then you do just buy it."

AMD (26:02 - 30:11):

• Performance: AMD hit a 52-week high after announcing a price hike on its high-end AI chips.
• Insight:

  Dan Nathan (26:19): "This is really bottom-up stuff. If discretionary spend changes a lot, you're looking at me kind of."

UnitedHealth (29:28 - 30:11):

• Performance: UnitedHealth's stock has plummeted 55% this year, significantly impacting the Dow Jones Industrial Average.
• Challenges: The company faces DOJ investigations into its Medicaid practices and higher medical loss ratios.
• Analyst Insight:

  Carter Braxton Worth (29:28): "There is so much uncertainty around the business... I am nowhere close to participating now."

5. Company Spotlight: Sarepta Therapeutics (16:47 - 19:35)

A detailed discussion on Sarepta Therapeutics’ stock movement following FDA updates on their gene therapy for Duchenne Muscular Dystrophy.

Key Points:

• FDA Decision: The FDA has approved the resumption of Sarepta’s gene therapy, Elevidis, for ambulatory patients, reversing a previous halt.
• Market Reaction: Shares surged over 50% in after-hours trading following the announcement.
• Financial Outlook: While Elevidis could generate approximately $500 million in annual sales, Sarepta still faces significant debt obligations and needs to navigate ongoing financial restructuring.

Notable Quotes:

Karen Feiderman (16:47): "The FDA has recommended that Sarepta can go ahead and resume shipments of that gene therapy Elevidis for patients with Duchenne muscular dystrophy who can still walk."

Dan Nathan (18:37): "Street is looking at, you know, $18 as a floor somewhere for at least in here."

6. Technical Analysis and Market Trends (38:37 - 42:18)

Carter Braxton Worth provides an in-depth technical analysis of the market indices, focusing on the S&P 500, Dow, Mid-Cap, and Equal Weight indices.

Key Points:

• S&P 500: Trading about 4% above its February high before a significant drop.
• Dow Jones & Mag 7: Both indices have recouped their losses and are near former highs but have yet to break new ground.
• S&P 400 Mid-Cap: Notably lagging, yet historically one of the best long-term performers.
• Market Breadth: Equal Weight S&P 500 mirrors Dow and Mag 7, indicating potential underlying strength but also risks if these indices fail to sustain higher levels.

Notable Quotes:

Carter Braxton Worth (38:37): "If it doesn't happen this week, it's a big telling thing."

Guy Adami (41:17): "You need to stick your landing... getting above a former high and staying above it versus faltering and putting in either a double top or what is known as a bull trap."

7. Options Trading Insights (43:13 - 45:43)

The panel examines options trading activities ahead of major earnings reports, particularly focusing on Starbucks.

Key Points:

• Starbucks Options Activity: Significant put options trading implies bearish sentiment ahead of earnings.
• Volatility Indicators: Market participants are preparing for potential price swings post-earnings.

Notable Quotes:

Angelica Peebles (43:13): "It traded well over two times its average daily put volume... $200,000 in premium being bet on those."

Dan Nathan (43:56): "I'm not sure that this is the quarter where you're going to suddenly feel. In fact, the stock has been meandering for the last six months and I think it will continue to my ass."

8. Volatility and the VIX (44:34 - 45:39)

Mike Khouw and Angelica Peebles discuss the implications of a steep contango in the VIX futures curve, indicating potential future market volatility.

Key Points:

• VIX Futures: The steep contango suggests that the market anticipates increased volatility in the coming months.
• Risk Management: Investors should be cautious of potential choppiness and prepare for possible market corrections.

Notable Quotes:

Angelica Peebles (44:34): "The options market is implying some real choppiness potentially towards the back half of the year."

Mike Khouw (44:34): "If you're able to squeeze that risk premium out further, it is even more incrementally positive for markets."

9. Final Trade Tips and Closing Remarks (45:11 - End)

In the concluding segment, panelists share their final trade recommendations and insights before signing off.

Key Points:

• Sarepta Trading: Anticipate volatility due to recent FDA approvals.
• Chinese Equities: Continued interest in tech giants like Alibaba and Tencent, despite ongoing trade tensions.
• Options Strategies: Cautious optimism with protective puts and selective long positions.

Notable Quotes:

Dan Nathan (45:21): "I still like gaming. I don't know that you have to get too far afield in terms of Chinese tech."

Carter Braxton Worth (45:29): "I'm long as you know, a very mag 7 heavy portfolio. I gotta have some protection buying more triple Q put spread."

Conclusion

This episode of CNBC's "Fast Money" provided a comprehensive analysis of a critical week for investors, marked by significant earnings reports, pivotal economic data releases, and ongoing US-China trade negotiations. The panel emphasized the importance of monitoring tariff impacts, Fed policies, and specific stock performances, while also highlighting the potential for increased market volatility. Investors are advised to remain vigilant, consider protective strategies, and stay informed as the market navigates through these multifaceted challenges.

For more detailed information, visit Fast Money on CNBC.